Cancer Scientist: This Common Daily Diet May Be Feeding Cancer!

Mitochondria act as an 'engine room' and 'brain' for the cell, controlling energy production and signaling the nucleus when to divide or slow down. When damaged, they lose efficient energy production (oxidative phosphorylation) and switch to less efficient fermentation, communicating with the nucleus to bring in more fuel (glucose and glutamine), thus driving uncontrolled cell growth.

Chronic stress, poor sleep, lack of exercise, highly processed carbohydrates, carcinogens (like microplastics, forever chemicals, glyphosate), viruses, and chronic inflammation are all factors that can chronically damage mitochondria, leading to inefficient energy production and increased cancer risk.

The GKI is a biomarker tool that measures the ratio of blood glucose to ketones to indicate mitochondrial metabolic health. Lower GKI values (e.g., 1.0-6.0) signify better metabolic health and lower risk for chronic diseases, while higher values indicate increased risk. It helps individuals track their metabolic state.

Conventional treatments like chemotherapy and radiation often cause massive oxidative stress, which cancer cells repair using immense amounts of glucose. Moreover, the waste products of fermentation (lactic and succinic acid) protect tumor cells from these therapies. Current treatments also fail to address the underlying metabolic issue.

A ketogenic diet restricts glucose, removing a primary fuel source for cancer cells. Healthy cells can efficiently burn ketones for energy, while cancer cells, due to damaged mitochondria, cannot. This marginalizes tumor cells and makes them more vulnerable to lower doses of conventional therapies, while simultaneously protecting healthy cells.

Metabolic therapy focuses on targeting the cancer cells' reliance on glucose and glutamine by inducing nutritional ketosis. By putting patients in ketosis, standard drugs and even immunotherapies can be used at lower, less toxic doses, enhancing their efficacy by making cancer cells more vulnerable and less aggressive.

Mainstream oncology primarily operates on the somatic mutation theory of cancer, focusing on genetics and DNA-targeting treatments. Oncologists are not typically trained in the biology and biochemistry of metabolic disease, and dietary interventions lack the institutional funding for massive clinical trials required for standard of care adoption.

Actions include avoiding highly processed carbohydrates, exercising regularly, prioritizing good sleep, reducing chronic emotional stress, and avoiding exposure to environmental carcinogens like microplastics and heavy metals in water. Education and lifestyle changes are key to keeping mitochondria healthy.

Fasting protocols, such as intermittent or water-only fasting, can drastically lower IGF-1, trigger cellular autophagy, and remove the metabolic shield of cancer cells (lactic and succinic acid). This makes standard cancer therapies significantly more effective by sensitizing tumor cells to damage while protecting healthy cells.

The 'press pulse' strategy involves 'pressing' down the glucose supply to the tumor (e.g., through a ketogenic diet) and then 'pulsing' with glutamine-targeting drugs to kill metastatic cancer cells. This approach aims for resolution by simultaneously weakening the tumor and enhancing the health of organs.